Showing 20,041 - 20,060 results of 101,532 for search '(( a web decrease ) OR ( 5 ((point decrease) OR (((nn decrease) OR (a decrease)))) ))', query time: 0.94s Refine Results
  1. 20041
  2. 20042
  3. 20043
  4. 20044

    Pain scores for each condition in Experiment 2 (<i>n</i> = 26). by Miki Matsumuro (12647119)

    Published 2022
    “…Moreover, the baseline was measured without the HMD prior to all experimental conditions. A negative score indicates that perceived pain decreased more than the baseline evaluation, whereas a positive score denotes that perceived pain increased more than the baseline evaluation. …”
  5. 20045
  6. 20046

    Effect of Ac-SDKP on cardiac rupture incidence, mortality rate, and infarct size in myocardial infarction. by Pablo Nakagawa (4794402)

    Published 2018
    “…<p>Out of 95 mice analyzed at 7 days post-MI, 38 died from cardiac rupture, and 5 died from other causes. In myocardial infarction, Ac-SDKP decreased A) incidence of cardiac rupture from 51.0% (vehicle treated) to 27.3% (Ac-SDKP treated) and B) mortality from 56.9% (vehicle treated) to 31.8% (Ac-SDKP treated). …”
  7. 20047
  8. 20048

    DataSheet_1_The miR-33a-5p/CROT axis mediates ovarian cancer cell behaviors and chemoresistance via the regulation of the TGF-β signal pathway.pdf by Xin Li (51274)

    Published 2022
    “…Thus, targeting the miR-33a-5p/CROT axis may have clinical potential for the treatment of patients with OC.…”
  9. 20049
  10. 20050

    Presentation3_Analysis of B-cell receptor repertoire to evaluate the immunogenicity of SARS-CoV-2 RBD mRNA vaccine: MAFB-7256a (DS-5670d).pptx by Goh Ohji (5205629)

    Published 2024
    “…<p>A monovalent Omicron XBB.1.5 mRNA RBD analogue vaccine, MAFB-7256a (DS-5670d), was newly developed and approved in Japan in the Spring of 2024 for the prevention of COVID-19. …”
  11. 20051

    Presentation2_Analysis of B-cell receptor repertoire to evaluate the immunogenicity of SARS-CoV-2 RBD mRNA vaccine: MAFB-7256a (DS-5670d).pptx by Goh Ohji (5205629)

    Published 2024
    “…<p>A monovalent Omicron XBB.1.5 mRNA RBD analogue vaccine, MAFB-7256a (DS-5670d), was newly developed and approved in Japan in the Spring of 2024 for the prevention of COVID-19. …”
  12. 20052

    Presentation1_Analysis of B-cell receptor repertoire to evaluate the immunogenicity of SARS-CoV-2 RBD mRNA vaccine: MAFB-7256a (DS-5670d).pptx by Goh Ohji (5205629)

    Published 2024
    “…<p>A monovalent Omicron XBB.1.5 mRNA RBD analogue vaccine, MAFB-7256a (DS-5670d), was newly developed and approved in Japan in the Spring of 2024 for the prevention of COVID-19. …”
  13. 20053

    Image_5_GPCR19 Regulates P2X7R-Mediated NLRP3 Inflammasomal Activation of Microglia by Amyloid β in a Mouse Model of Alzheimer’s Disease.tif by Jahirul Islam (11280516)

    Published 2022
    “…Furthermore, TDCA enhanced phagocytosis of Aβ and decreased the number of Aβ plaques in the brains of 5x Familial Alzheimer’s disease (5xFAD) mice. …”
  14. 20054

    Data_Sheet_1_Biochemical analyses of a novel acidophilic GH5 β-mannanase from Trichoderma asperellum ND-1 and its application in mannooligosaccharides production from galactomannan... by Fengzhen Zheng (6084443)

    Published 2023
    “…<p>In this study, an acidophilic GH5 β-mannanase (TaMan5) from Trichoderma asperellum ND-1 was efficiently expressed in Pichia pastoris (a 2.0-fold increase, 67.5 ± 1.95 U/mL). …”
  15. 20055

    Supplemental figures for manuscript entitled: Tumor Suppressors RBL1 and PTEN are Epigenetically Silenced in IPF Mesenchymal Progenitor Cells by a CD44/Brg1/PRMT5 Regulatory Comple... by Craig Henke (9406202)

    Published 2024
    “…<p dir="ltr">The IPF lung contains mesenchymal progenitor cells (MPCs) that display durable activation of oncogenic signaling and cell-autonomous fibrogenicity <i>in vivo</i>. Prior work identified a CD44/Brg1/PRMT5 nuclear regulatory module in IPF MPCs that increased expression of genes positively regulating pluripotency and self-renewal. …”
  16. 20056
  17. 20057
  18. 20058

    The prognostic value of the neutrophil-percentage-to-albumin ratio for all-cause and cardiovascular mortality in chronic kidney disease stages G3a to G5: insights from NHANES 2003–... by Jialing Rao (20354623)

    Published 2025
    “…<p>Patients with chronic kidney disease (CKD) stages G3a to G5 frequently experience heightened systemic inflammation and nutritional loss. …”
  19. 20059
  20. 20060

    DataSheet_1_Bidirectional Action of Cenicriviroc, a CCR2/CCR5 Antagonist, Results in Alleviation of Pain-Related Behaviors and Potentiation of Opioid Analgesia in Rats With Periphe... by Klaudia Kwiatkowski (9118247)

    Published 2020
    “…In parallel, administration of cenicriviroc decreased the expression of CCR2 in the spinal cord and CCR5 in DRG. …”